Weight Loss for Kidney Stones

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Kidney StonesWeight Loss - Behavioral
Eligibility
21 - 99
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the effects of a weight loss program with or without the drug Pio on obese people with type 2 diabetes.

Eligible Conditions
  • Kidney Stones

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 24 weeks

24 weeks
Uric acid
Urine Ammonium/Net Acid Excretion
Urine Net Acid Excretion/Sulphate
Urine pH

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Pioglitazone Drug (including Placebo)
1 of 2
Weight Loss, Behavioral
1 of 2

Experimental Treatment

54 Total Participants · 2 Treatment Groups

Primary Treatment: Weight Loss · No Placebo Group · Phase 4

Pioglitazone Drug (including Placebo)
Drug
Experimental Group · 1 Intervention: Pioglitazone 45 mg · Intervention Types: Drug
Weight Loss, Behavioral
Behavioral
Experimental Group · 1 Intervention: Weight Loss · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Weight Loss
2008
Completed Phase 3
~1380
Pioglitazone
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
952 Previous Clinical Trials
607,870 Total Patients Enrolled
3 Trials studying Kidney Stones
505 Patients Enrolled for Kidney Stones
Khashayar Sakhaee, MDPrincipal Investigator - UTSW
Children's Medical Center of Dallas, The University of Texas Southwestern Medical Center At Dallas, UT Southwestern Medical Center-Zale Lipshy Campus
Shiraz University Of Medical Sci & Hlth Serv (Medical School)
Vet Affairs Medical Center (Residency)
3 Previous Clinical Trials
122 Total Patients Enrolled

Eligibility Criteria

Age 21 - 99 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: